Suggested for -nE:
Evaluating patients with suspected autoimmune encephalitis and autoimmune epilepsy using spinal fluid specimens
GENPA - Overview: Gentamicin, Peak, Serum
Monitoring adequacy of drug clearance during gentamicin therapy
GENRA - Overview: Gentamicin, Random, Serum
Monitoring adequacy of serum concentration during gentamicin therapy in specimens for which no collection timing information is provided
GELA - Overview: Gelatin, IgE, Serum
Establishing a diagnosis of an allergy to gelatin Defining the allergen responsible for eliciting signs and symptoms Identifying allergens: -Responsible for allergic response and/or anaphylactic episode -To confirm sensitization prior...
LGB3S - Overview: Globotriaosylsphingosine, Serum
Diagnosis and monitoring of Fabry disease
GALCR - Overview: Galactocerebrosidase Reflex, Leukocytes
Diagnosis of Krabbe disease as a confirmatory reflex of the six-enzyme panel Follow-up testing for evaluation of an abnormal newborn screening result for Krabbe disease This test is not recommended for carrier detection because of the...
FGLIP - Overview: Glipizide (Glucotrol)
Glipizide (Glucotrol)
FGABA - Overview: Gabapentin, Urine
Gabapentin, Urine
FGAGA - Overview: Golimumab and Anti-Golimumab Antibody, DoseASSURE GOL
Golimumab and Anti-Golimumab Antibody, DoseASSURE GOL
GPSYP - Overview: Glucopsychosine, Plasma
Second-tier test when newborn screening results with reduced beta-glucosidase (GBA) activity are identified Diagnosis and monitoring of patients with Gaucher disease using plasma specimens Supporting a biochemical diagnosis of Gaucher...